drug

gadoquatrane

1 story · latest Oct 8, 2026

Follow gadoquatrane. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Jun 2026 · NDA219627
Brand: Ambelvist

Relationships

Developed by Bayer

Timeline

Bayer posts Phase 3 gadoquatrane brain/spine MRI results; ARI2 Eylea data remain on file

Oct 8Weekly roundup, 2 itemsaflibercept BayerUpdated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.